{"id":"ly01015","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"LY01015 is an investigational compound in phase 3 development by Shandong Boan Biotechnology. Limited public information is available regarding its precise molecular mechanism and target. The drug is being evaluated for therapeutic potential, but detailed mechanistic data has not been widely disclosed in accessible literature.","oneSentence":"LY01015 is a small molecule inhibitor that targets a specific molecular pathway involved in disease pathogenesis.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:19:51.125Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT06022861","phase":"PHASE3","title":"A Study to Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Carcinoma","status":"RECRUITING","sponsor":"Shandong Boan Biotechnology Co., Ltd","startDate":"2023-10-12","conditions":"Esophageal Squamous Cell Carcinoma","enrollment":510}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"LY01015","genericName":"LY01015","companyName":"Shandong Boan Biotechnology Co., Ltd","companyId":"shandong-boan-biotechnology-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}